This site is intended for healthcare professionals residing in Canada.

Visit Pfizer AcademySearch

Menu

Close

Sign InLog Out
  • EN
ProductsTherapy AreasExplore ContentExplore
ContentGo to Explore ContentEventsMaterialsVideosPatient SupportContact
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Français

Menu

Close

Home

Recommendations

SOGC Recommendations

NACI Recommendations

CIQ Recommendations

About RSV

About RSV

Infants at Risk

Individuals ≥ 60 Years of Age

About ABRYSVO

Reconstitution and Storage

Dosing and Administration

Mechanism of Action

Efficacy and Safety Profiles

Clinical Trials

MATISSE Study Design

MATISSE Data

MATISSE Safety Profile

RENOIR Study Design

RENOIR Data

RENOIR Safety Profile

More

Coverage Information

Patient Profiles

FAQ

Resources

Product MonographSafety Information
Pfizer Respiratory Vaccine Portfolio
Recommendations from the SOGCAn RSV immunization strategy is recommended for all infants to prevent infant RSV infection1

When discussing RSV immunization for the individual patient, a shared decision-making approach should be considered.

TitleTo see the complete statement, click here.

SOGC: Society of Obstetricians and Gynaecologists of Canada; RSV: respiratory syncytial virus

SOGC: Society of Obstetricians and Gynaecologists of Canada; RSV: respiratory syncytial virus

SOGC: Society of Obstetricians and Gynaecologists of Canada; RSV: respiratory syncytial virusReference:Society of Obstetricians and Gynaecologists of Canada. SOGC statement on RSV immunization to prevent infant RSV infection. Accessed September 16, 2024. https://sogc.org/common/Uploaded%20files/Position%20Statements/SOGC%20Statement%20RSV_07182024_EN.pdf.RecommendationsAbout RSV

Learn more about respiratory syncytial virus and its impact on high-risk populations.

PP-A1G-CAN-0117-EN

To report an adverse event, please call 1-866-723-7111

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out

© Pfizer Canada ULC 2024. All rights reserved. The information is intended only for healthcare professionals resident in Canada. ®Pfizer Inc., used under license.

PP-UNP-CAN-0145-EN
You are now leaving Pfizerpro.ca website
Links to other sites are provided as a convenience to the viewer, and should not be taken as an endorsement of the sites or an association with their owners. Pfizer Canada accepts no responsibility for the content of linked sites.
You are now leaving the PfizerPro Portal.
You are about to view resources made available by Pfizer Academy. 
These resources include learning programs and upcoming events. By selecting Go to link below, you acknowledge and certify that you are a Canadian Healthcare Professional.
PP-UNP-CAN-0013 EN
Are you a resident of Quebec?